I agree that this site is using cookies. You can find further informations here.
X
Heiblig, Maël
109  results:
Search for persons X
?
1

Allogeneic hematopoietic cell transplantation for VEXAS syn..:

Gurnari, Carmelo ; Koster, Linda ; Baaij, Laurien...
Blood Advances.  8 (2024)  6 - p. 1444-1448 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Efficacy and safety of mammalian target of rapamycin inhibi..:

Moraly, Josquin ; Rossignol, Julien ; Rouzaud, Claire...
American Journal of Hematology.  99 (2024)  6 - p. 1095-1102 , 2024
Link: https://doi.org/10.1002/..
 
?
3

P1135: EFFECT OF GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-..:

Pierre, Sabrina ; Heiblig, Maël ; Nourredine, Mikaïl...
HemaSphere.  7 (2023)  S3 - p. e62941c4 , 2023
Link: https://doi.org/10.1097/..
 
?
4

Clinical outcome of therapy‐related acute myeloid leukemia ..:

Belhabri, Amine ; Heiblig, Mael ; Morisset, Stephane...
Cancer Medicine.  12 (2023)  16 - p. 16929-16944 , 2023
Link: https://doi.org/10.1002/..
 
?
5

POSTER: AML-475 Activity, Tolerability, and Resistance Prof..:

Erba, Harry ; Wang, Eunice ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S168 , 2023
Link: https://doi.org/10.1016/..
 
?
6

LSC17 score complements genetics and measurable residual di..:

Vasseur, Loïc ; Fenwarth, Laurène ; Lambert, Jérôme...
Blood Advances.  7 (2023)  15 - p. 4024-4034 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Sickle cell disease and acute leukemia: one case report and..:

Cannas, Giovanna ; Poutrel, Solène ; Heiblig, Maël...
Annals of Hematology.  102 (2023)  7 - p. 1657-1667 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Use of tamibarotene, a potent and selective RARα agonist, i..:

Stein, Eytan M. ; de Botton, Stephane ; Cluzeau, Thomas...
Leukemia & Lymphoma.  64 (2023)  12 - p. 1992-2001 , 2023
Link: https://doi.org/10.1080/..
 
?
9

VEXAS syndrome, a new kid on the block of auto-inflammatory..:

Heiblig, Maël ; Patel, Bhavisha ; Jamilloux, Yvan
Best Practice & Research Clinical Rheumatology.  37 (2023)  1 - p. 101861 , 2023
Link: https://doi.org/10.1016/..
 
?
10

From vacuoles to VEXAS:

Heiblig, Maël ; Sujobert, Pierre
Rheumatology.  62 (2023)  12 - p. 3780-3781 , 2023
Link: https://doi.org/10.1093/..
 
?
11

POSTER: AML-454 Real-World Use of Azacitidine (AZA) and Ven..:

Heiblig, Maël ; Tavernier, Emmanuelle ; Requena, Gaspar Aspas...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S163 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Recurrent Mutations of the Active Adenylation Domain of UBA..:

Faurel, Alyx ; Heiblig, Maël ; Kosmider, Olivier...
HemaSphere.  7 (2023)  4 - p. e868 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Impact on Outcome of Minimal Residual Disease after Hematop..:

Meur, Grégoire Le ; Plesa, Adriana ; Larcher, Marie-Virginie...
Transplantation and Cellular Therapy.  29 (2023)  1 - p. 38.e1-38.e9 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PAR..:

Antherieu, Gabriel ; Heiblig, Maël ; Freyer, Gilles..
Drugs & Aging.  40 (2023)  5 - p. 397-405 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Chronic myelomonocytic leukemia transdifferentiation landsc..:

Antherieu, Gabriel ; Donzel, Marie ; Balme, Brigitte..
American Journal of Hematology.  98 (2023)  8 - p. 1343-1345 , 2023
Link: https://doi.org/10.1002/..
 
1-15